Aldeyra operating chief bids adieu

• In a regulatory filing, Aldeyra Therapeutics (NASDAQ:ALDX) reports that Chief Operating Officer Scott Young resigned effective August 30 by mutual agreement. The specific reasons for the move are not provided.